Search

Your search keyword '"Jean-Pierre Bayley"' showing total 66 results

Search Constraints

Start Over You searched for: Author "Jean-Pierre Bayley" Remove constraint Author: "Jean-Pierre Bayley"
66 results on '"Jean-Pierre Bayley"'

Search Results

1. Long-term in vitro 2D-culture of SDHB and SDHD-related human paragangliomas and pheochromocytomas.

2. Sdhd and SDHD/H19 knockout mice do not develop paraganglioma or pheochromocytoma.

3. SDHB variant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma

4. International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma

5. Hypothesis: Why Different Types of SDH Gene Variants Cause Divergent Tumor Phenotypes

6. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma–paraganglioma

7. Germline DLST variants promote epigenetic modifications in pheochromocytoma-paraganglioma

8. International initiative for a curated

9. Advances in paraganglioma-pheochromocytoma cell lines and xenografts

10. The phenotype of SDHB germline mutation carriers

11. Mathematical Models for Tumor Growth and the Reduction of Overtreatment

12. Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas

13. Simple and rapid characterization of novel large germline deletions inSDHB,SDHCandSDHD-related paraganglioma

14. Clinical progression and metachronous paragangliomas in a large cohort of SDHD germline variant carriers

15. A novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family-based study

16. 65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytoma

17. Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis

18. No difference in phenotype of the main DutchSDHDfounder mutations

19. The phenotype of

20. Measurement of head and neck paragangliomas: is volumetric analysis worth the effort? A method comparison study

21. Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier in SDHD-linked paragangliomas: SLC22A18 and CDKN1C are candidate tumour modifiers

22. Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients

23. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands

24. Mutation of SDHB is a Cause of Hypoxia-Related High-Altitude Paraganglioma

25. Increased Urinary Excretion of 3-Methoxytyramine in Patients with Head and Neck Paragangliomas

26. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients

27. No evidence for increased mortality in SDHD variant carriers compared with the general population

28. Models of parent-of-origin tumorigenesis in hereditary paraganglioma

29. Differentially methylated alleles in a distinct region of the human interleukin-1alpha promoter are associated with allele-specific expression of IL-1alpha in CD4+ T cells

30. Analysis of allelic expression patterns of IL-2, IL-3, IL-4, and IL-13 in human CD4+ T cell clones

31. Allele-specific expression of the IL-1 alpha gene in human CD4+ T cell clones

32. Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors

33. Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum

34. Phenotype of SDHB mutation carriers in the Netherlands

35. Paraganglioma and pheochromocytoma upon maternal transmission of SDHDmutations

36. Lymphocyte Homing and Ig Secretion in the Murine Mammary Gland

37. FUNCTIONAL ANALYSIS OF LINKER-SCAN MUTANTS SPANNING THE −376, −308, −244, AND −238 POLYMORPHIC SITES OF THE TNF-α PROMOTER

38. The role of complex II in disease

39. High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations

40. Association of polymorphisms of the tumour necrosis factor receptors I and II and rheumatoid arthritis

41. Normal Life Expectancy for Paraganglioma Patients: A 50-Year-Old Cohort Revisited

42. The Warburg effect in 2012

43. Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma

44. SDHA Immunohistochemistry Detects Germline SDHA Gene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas

45. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis

46. SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma

47. Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree?

48. The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family

49. Low penetrance of a SDHB mutation in a large Dutch paraganglioma family

50. Sdhd and SDHD/H19 knockout mice do not develop paraganglioma or pheochromocytoma

Catalog

Books, media, physical & digital resources